Moderate Hypothermia Modifies Coronary Hemodynamics and Endothelium‐Dependent Vasodilation in a Porcine Model of Temperature Management

Figure 1. Flow chart illustrating study design with the assessments performed at each temperature time point (A) and the protocol of intracoronary drug administration (B). APV indicates average peak velocity; CAG, coronary angiography; CFR, coronary flow reserve; CHx, coronary hemodynamics; FFR fractional flow reserve; MR, microvascular resistance.

Figure 2. Invasive assessment of coronary hemodynamics by Doppler wire. A, Depiction of each coronary hemodynamic variable studied by Doppler wire (black arrow) and its relevance based on coronary vascular compartments. B, Representative coronary angiography showing the retrograde positioning of the Doppler wire in the left circumflex coronary artery (yellow arrow) and a selected branch used to study drug‐induced vasodilation by measuring the diameter before and after each drug challenge (yellow dotted lines). bAPV indicates basal average peak velocity; CFR, coronary flow reserve; ∅, diameter; FFR, fractional flow reserve; MR, microvascular resistance; pAPV, peak average peak velocity; QCA, quantitative coronary analysis.

Figure 3. Effects of temperature on coronary vasodilation. A, Left and right parts of the bar chart show similar percent change in diameter after administration of endothelium‐independent vasodilator (nitroglycerin) along rewarming and moderate hypothermia (MoHT) protocols, respectively. B, Right bars (MoHT protocol) show an effect of temperature on endothelium‐dependent vasodilation with a significant increase in the percent change of diameter after administering bradykinin at 32°C time point. Left part of the bar chart (rewarming protocol) shows no differences in coronary vasodilation after bradykinin administration in the rewarming protocol. C, Bar chart depicts no statistical differences in the percent change in diameter at hyperemia (ATP) between time points in either protocol.

Figure 4. In vitro vasorelaxation of temperature preconditioned coronary rings. A, Left chart depicts increased relaxation of arteries from moderate hypothermia (MoHT), in comparison with the rewarming protocol, when challenged with bradykinin, a pure endothelium‐dependent vasodilator. ATP relaxation curves also showed a greater potential to relax in MoHT rings, compared with rewarming, as shown in the right chart. B, Treatment with the nonselective NO inhibitor, N(ω)‐nitro‐L‐arginine methyl ester (l‐NAME), resulted in a complete suppression of bradykinin‐ (left chart) and ATP‐induced (right chart) relaxation in coronary rings from the MoHT protocol. On the other hand, l‐NAME did not modify the bradykinin relaxation curve (left chart) and augmented the potential of relaxation induced by ATP (right chart) in rings from the rewarming protocol. C, Indomethacin, a cyclooxygenase inhibitor, did not modify either bradykinin‐ (left chart) or ATP‐induced (right chart) relaxation curves in either protocol.

Figure 5. Main effects of moderate hypothermia (MoHT) in coronary vasculature. Briefly, MoHT (right) was associated with slowed coronary velocity (long arrows inside the coronary artery), augmented microvascular resistance (represented as grey short arrows pointing out small vessels), and increased endothelium‐derived vasodilatory capacity (dotted lines around the schematic representation of a coronary branch) associated with greater NO activity in comparison with reference parameters at normothermia (left).